New research suggests in-womb gene correction

April 05, 2020

New research led by hearing scientists at Oregon Health & Science University suggests an avenue to treat and prevent intractable genetic disorders before birth.

Researchers at the Oregon Hearing Research Center, working with mice, injected a specially designed synthetic molecule into the developing inner ear of fetal mice 12 days after fertilization. The study found that the technique corrected the expression of a mutated gene that causes Usher syndrome, a disorder characterized by deafness and progressive vision loss affecting an estimated 4 to 17 of every 100,000 people.

The technique does not directly translate to clinical applications in people. However, the new research combined with previous findings suggests it may be possible to deliver the drug therapy through amniotic fluid in the womb to the fetus.

The findings will be published in the journal Nucleic Acids Research.

Scientists designed a synthetic antisense oligonucleotide, or ASO, which targets and then attaches to precise nucleic acid sequences. In this case, the molecule was designed to target pre-messenger RNA, a class of molecules that influences when, where, and how strongly genes are expressed in a cell. When scientists injected the ASO into the developing inner ear of fetal mice carrying the gene mutation, the mice developed with no symptoms of Usher syndrome.

"This shows that direct administration of the ASO to the inner ear restored hearing and balance," said senior author John V. Brigande, Ph.D., principle investigator for the Oregon Hearing Research Center at OHSU.

Researchers expect to move from a mouse model to nonhuman primates, which more closely model human hearing loss, before the technique would be ready for human clinical trials. Brigande said he expects it will be useful in potentially treating and preventing several types of congenital forms of hearing and balance disorders.

This work represents the latest in several OHSU initiatives to develop new genetic tools to address genetic conditions.

Recently, researchers in the OHSU Casey Eye Institute for the first time used another gene editing technique called CRISPR to edit genes within the human body. In 2017, OHSU researchers generated worldwide attention when they corrected a gene mutation that causes a deadly heart condition in early human embryos.

"In our complementary approach to gene editing in early-stage embryos in a dish, we seek to correct aberrant gene expression in the fetal inner ear while inside the uterus to restore hearing and balance," Brigande said. "We think both approaches have high merit."
-end-
This work was supported by grants from the Foundation Fighting Blindness; the National Institute on Deafness and Other Communication Disorders of the National Institutes of Health, including grant numbers R01-DC012596 and RO1-DC014160; National Eye Institute grant R01-EY030499; the National Institute on General Medical Sciences, including grants U54 GM104940 and P30 GM103340; grant number P30 NS061800 from the National Institute on Neurological Disorders and Stroke of the NIH; and donations from the Usher 2020 Foundation and the Ush One See Foundation. All work with animals was reviewed and approved by the OHSU Institutional Animal Care and Use Committee.

Co-author Frank Rigo, Ph.D., is an employee of Ionis Pharmaceuticals, and co-author Jennifer J. Lentz, Ph.D., Associate Professor of Otorhinolaryngology & Biocommunications and Neuroscience, Adjunct Associate Professor of Ophthalmology, Louisiana State University School of Medicine, has served as a consultant for Decibel Therapeutics.

Oregon Health & Science University

Related Gene Mutation Articles from Brightsurf:

New gene mutation associated with Fabry cardiomyopathy
The A143T variant of the GLA gene is associated with an increased risk of Fabry cardiomyopathy, according to a new study.

How gene mutation causes autism and intellectual disability
Scientists have discovered why a specific genetic mutation causes intellectual disability and autism spectrum disorder in children.

Researchers identify new gene mutation in familial thyroid cancers
Researchers from Penn State College of Medicine identified a new gene mutation that may cause a type of familial thyroid cancer.

Researcher discovers gene mutation that contributes to addiction
A researcher at the OU College of Medicine, William R.

Researchers find new mutation in the leptin gene
Texas Biomed Staff Scientist Raul Bastarrachea, M.D., is part of a team that discovered a new mutation in the gene that regulates the key hormone suppressing hunger called leptin.

Cryptic mutation is cautionary tale for crop gene editing
Unexpected interactions between mutations can be a thorn in the side for plant breeders.

Woman with novel gene mutation lives almost pain-free
A woman in Scotland can feel virtually no pain due to a mutation in a previously-unidentified gene, according to a research paper co-led by UCL.

Cancer: A mutation that breaks gene interplay in 3D
EPFL scientists have discovered how a mutated gene can affect the three-dimensional interactions of genes in the cell, leading to various forms of cancer.

Novel gene mutation found in lymphatic disorder
Pediatric researchers have identified a gene mutation that causes a serious lymphatic condition, and used that knowledge to restore normal lymphatic vessels in model animals.

New options for targeting gene mutation in FA described in nucleic acid therapeutics
Researchers have shown that a wide variety of synthetic antisense oligonucleotides with different chemical modifications can activate the frataxin gene, which contains a mutation that decreases its expression in the inherited neurologic disorder Friedreich's ataxia (FA).

Read More: Gene Mutation News and Gene Mutation Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.